2016

Obtaining Consent in International Clinical Research: Key Considerations

Visit USCO

Text Registration

Obtaining Consent in International Clinical Research: Key Considerations

Status

Published

on 30 Jun 2016

Year of Creation

2016

Washington Business Information, Inc

Registration Number

TX0008580627

on 30 Jun 2016

The U.S. Copyright record (Registration Number: TX0008580627) dated 30 Jun 2016, pertains to an electronic file (eService) titled "Obtaining Consent in International Clinical Research: Key Considerations" created in 2016. The copyright holder is Washington Business Information, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Washington Business Information, Inc.

Washington Business Information, Inc

Application Details

Registration Number

TX0008580627

Registration Date

6/30/2016

Year of Creation

2016

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Washington Business Information, Inc FDAnews

Physical Description

Electronic file (eService)

First Publication Nation

United States

ISBN

978-1-60428-308-2

Preexisting Material

Appendices

Corporate Authors

Inc Washington Business Information

FDAnews

Notes

Rights Note: Jodi Grizzel, Washington Business Information, Inc., 300 N. Washington St., Suite 200, Falls Church, VA, 22046, (703) 538-7600, (703) 538-7636, jbgrizzel@fdanews.com

Local Copyright Note: C.O. correspondence

Material Matter Claimed Note: text, Pages 1-16

Statements

Application Title Statement: Obtaining Consent in International Clinical Research: Key Considerations

Author Statement: Washington Business Information, Inc d.b.a. FDAnews employer for hire Domicile: United States Authorship: text

Notes

Rights Note: Jodi Grizzel, Washington Business Information, Inc., 300 N. Washington St., Suite 200, Falls Church, VA, 22046, (703) 538-7600, (703) 538-7636, jbgrizzel@fdanews.com

Local Copyright Note: C.O. correspondence

Material Matter Claimed Note: text, Pages 1-16

Statements

Application Title Statement: Obtaining Consent in International Clinical Research: Key Considerations

Author Statement: Washington Business Information, Inc d.b.a. FDAnews employer for hire Domicile: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.